Baillie Gifford & Co. Sells 516,983 Shares of Cardlytics, Inc. (NASDAQ:CDLX)

Baillie Gifford & Co. cut its stake in Cardlytics, Inc. (NASDAQ:CDLXFree Report) by 91.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 50,413 shares of the company’s stock after selling 516,983 shares during the period. Baillie Gifford & Co.’s holdings in Cardlytics were worth $187,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of CDLX. RBF Capital LLC lifted its position in Cardlytics by 311.9% in the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock worth $1,562,000 after buying an additional 369,620 shares during the last quarter. GSA Capital Partners LLP lifted its position in Cardlytics by 1,273.2% in the third quarter. GSA Capital Partners LLP now owns 382,315 shares of the company’s stock worth $1,223,000 after buying an additional 354,474 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its position in shares of Cardlytics by 56.0% during the third quarter. Jacobs Levy Equity Management Inc. now owns 317,644 shares of the company’s stock worth $1,016,000 after purchasing an additional 113,966 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Cardlytics by 7.5% during the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock worth $3,371,000 after purchasing an additional 73,484 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Cardlytics during the third quarter worth $153,000. 68.10% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Craig Hallum upgraded Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Friday, January 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $6.92.

Check Out Our Latest Stock Report on CDLX

Insider Activity

In other news, CFO Alexis Desieno sold 8,854 shares of the company’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $3.67, for a total transaction of $32,494.18. Following the transaction, the chief financial officer now owns 121,976 shares in the company, valued at $447,651.92. This represents a 6.77 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Amit Gupta sold 15,160 shares of the company’s stock in a transaction dated Friday, January 24th. The shares were sold at an average price of $3.92, for a total transaction of $59,427.20. Following the transaction, the chief executive officer now owns 215,494 shares in the company, valued at approximately $844,736.48. This trade represents a 6.57 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 64,597 shares of company stock worth $232,550 over the last 90 days. 4.40% of the stock is currently owned by corporate insiders.

Cardlytics Stock Performance

Shares of Cardlytics stock opened at $3.37 on Wednesday. Cardlytics, Inc. has a 12 month low of $2.76 and a 12 month high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The firm has a market cap of $171.26 million, a P/E ratio of -0.55 and a beta of 1.54. The stock’s fifty day moving average price is $3.47 and its 200-day moving average price is $3.73.

Cardlytics Company Profile

(Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Articles

Want to see what other hedge funds are holding CDLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardlytics, Inc. (NASDAQ:CDLXFree Report).

Institutional Ownership by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.